Sonoma Pharmaceuticals (SNOA) Stock Is Flying As Its Product Passes Key Tests

Sonoma Pharmaceuticals SNOA Stock News

Sonoma Pharmaceuticals Inc (NASDAQ: SNOA) is having an incredibly strong start to the trading session this morning, and for good reason. The company announced that its disinfectant and sanitizer passed key tests for use in airlines. Here’s what’s going on:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

SNOA Rockets On Product uccess

In the press release, Sonoma Pharmaceuticals announced that MicroSafe Disinfectant & Sanitizer has successfully passed both the Boeing Specification Standard BSS7434 and the British Aerospace Airbus specification AIMS09-00-002.

This is overwhelmingly positive. As a result of the passing of these tests, MicroSafe has validated its product as a safe and effective wy to disinfect and sanitize the interior and exterior parts and materials of Boeing and Airbus commercial transport aircraft. Of course, this is important for SNOA as the company manufactures the product.

In a statement, Mrs. Safa Qadumi, Founder and CEO of the MicroSafe Group, had the following to offer:

Conforming with the material compatibility standards set forth by Boeing & Airbus, together with our 30 second kill time of bacteria & viruses on hard surfaces, allows us to advance the use of Microsafe® Disinfectant & Sanitizer into the airline industry. Recently, Microsafe® Disinfectant & Sanitizer (brand name “Nanocyn” in Australia) was approved and entered into the Australian Register of Therapeutic Goods (ARTG) for use against SARS-CoV-2 (COVID-19) with a 30 second kill time.

It’s important to note, that the Microsafe® Disinfectant & Sanitizer has been successfully used for nearly 20 years globally to fight the spread of infectious disease and during this time, we have earned numerous global regulatory approvals and amassed reputable scientific evidence not only as a surface disinfectant, but as a skin and wound antiseptic as well.

The above statement was followed up by Amy Trombly, CEO at SNOA. Here’s what she had to say:

We are excited that these tests show that use of our Microcyn® technology conforms to aircraft manufacturer standards. These test results expand our potential sales channels into the airline industry. As disinfectant and sanitizer use has increased due to the pandemic that has spread around the world, we are excited to work with our partners, like MicroSafe Group, to make a positive difference by providing safer environments for people during this difficult time. As an international company selling products in 53 countries around the world, we are continuously seeking additional partners to expand our domestic and global reach in distributing our products.

This Is Big News

The news proved to be overwhelmingly positive for both Sonoma Pharmaceuticals and MicroSafe. At the end of the day, the fact that these key tests have been passed means that these disinfectant and sanitizing products are likely to find their way into airlines, generating meaningful revenue ahead.

Considering the state of the COVID-19 pandemic, the demand for these types of products has never been higher. With the successful passing of key tests, demand likely to rise, and revenue likely to follow, SNOA is a stock that’s well worth watching!

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Don’t Miss The Next Big Story

Join our free mailing list below to receive real-time news alerts!

Subscribe Today!

* indicates required

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.